215 related articles for article (PubMed ID: 29019267)
1. GE11 peptide conjugated selenium nanoparticles for EGFR targeted oridonin delivery to achieve enhanced anticancer efficacy by inhibiting EGFR-mediated PI3K/AKT and Ras/Raf/MEK/ERK pathways.
Pi J; Jiang J; Cai H; Yang F; Jin H; Yang P; Cai J; Chen ZW
Drug Deliv; 2017 Nov; 24(1):1549-1564. PubMed ID: 29019267
[TBL] [Abstract][Full Text] [Related]
2. GE11 peptide modified and reduction-responsive hyaluronic acid-based nanoparticles induced higher efficacy of doxorubicin for breast carcinoma therapy.
Hu D; Mezghrani O; Zhang L; Chen Y; Ke X; Ci T
Int J Nanomedicine; 2016; 11():5125-5147. PubMed ID: 27785019
[TBL] [Abstract][Full Text] [Related]
3. GE11 peptide-conjugated nanoliposomes to enhance the combinational therapeutic efficacy of docetaxel and siRNA in laryngeal cancers.
Xu WW; Liu DY; Cao YC; Wang XY
Int J Nanomedicine; 2017; 12():6461-6470. PubMed ID: 28919747
[TBL] [Abstract][Full Text] [Related]
4. Angelica Sinensis Polysaccharide-Based Nanoparticles for Liver-Targeted Delivery of Oridonin.
Sun H; Nai J; Deng B; Zheng Z; Chen X; Zhang C; Sheng H; Zhu L
Molecules; 2024 Feb; 29(3):. PubMed ID: 38338476
[TBL] [Abstract][Full Text] [Related]
5. EGFR-targeting peptide conjugated polymer-lipid hybrid nanoparticles for delivery of salinomycin to osteosarcoma.
Du L; Xu Y; Han B; Wang Y; Zeng Q; Shao M; Yu Z
J Cancer Res Ther; 2023 Dec; 19(6):1544-1551. PubMed ID: 38156920
[TBL] [Abstract][Full Text] [Related]
6. Multifunctional selenium nanoparticles as carriers of HSP70 siRNA to induce apoptosis of HepG2 cells.
Li Y; Lin Z; Zhao M; Xu T; Wang C; Xia H; Wang H; Zhu B
Int J Nanomedicine; 2016; 11():3065-76. PubMed ID: 27462151
[TBL] [Abstract][Full Text] [Related]
7. Silencing of MEF2D by siRNA Loaded Selenium Nanoparticles for Ovarian Cancer Therapy.
Wang C; Xia Y; Huo S; Shou D; Mei Q; Tang W; Li Y; Liu H; Zhou Y; Zhu B
Int J Nanomedicine; 2020; 15():9759-9770. PubMed ID: 33304100
[TBL] [Abstract][Full Text] [Related]
8. Oridonin Promotes Apoptosis and Restrains the Viability and Migration of Bladder Cancer by Impeding TRPM7 Expression via the ERK and AKT Signaling Pathways.
Che X; Zhan J; Zhao F; Zhong Z; Chen M; Han R; Wang Y
Biomed Res Int; 2021; 2021():4340950. PubMed ID: 34285910
[TBL] [Abstract][Full Text] [Related]
9. Intra-Articular Formulation of GE11-PLGA Conjugate-Based NPs for Dexamethasone Selective Targeting-In Vitro Evaluation.
Chiesa E; Pisani S; Colzani B; Dorati R; Conti B; Modena T; Braekmans K; Genta I
Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30082640
[TBL] [Abstract][Full Text] [Related]
10. Functionalized siRNA-chitosan nanoformulations promote triple-negative breast cancer cell death via blocking the miRNA-21/AKT/ERK signaling axis: in-silico and in vitro studies.
Abdulmalek SA; Saleh AM; Shahin YR; El Azab EF
Naunyn Schmiedebergs Arch Pharmacol; 2024 Apr; ():. PubMed ID: 38592437
[TBL] [Abstract][Full Text] [Related]
11. PolyIC GE11 polyplex inhibits EGFR-overexpressing tumors.
Abourbeh G; Shir A; Mishani E; Ogris M; Rödl W; Wagner E; Levitzki A
IUBMB Life; 2012 Apr; 64(4):324-30. PubMed ID: 22362419
[TBL] [Abstract][Full Text] [Related]
12. Oridonin inhibits the occurrence and development of colorectal cancer by reversing the Warburg effect via reducing PKM2 dimer formation and preventing its entry into the nucleus.
Chen F; Liao J; Wu P; Cheng L; Ma Y; Zhang L; Leng X; Zhu X; Liu Z; Xie F
Eur J Pharmacol; 2023 Sep; 954():175856. PubMed ID: 37321470
[TBL] [Abstract][Full Text] [Related]
13. Sol-gel synthesis and cytotoxicity evaluation of selenium-doped cerium oxide nanoparticles for biomedical applications.
Javid H; Amiri H; Hashemi SF; Reihani A; Esparham A; Hashemy SI
Naunyn Schmiedebergs Arch Pharmacol; 2024 May; 397(5):3437-3447. PubMed ID: 37962586
[TBL] [Abstract][Full Text] [Related]
14. GE11 Peptide as an Active Targeting Agent in Antitumor Therapy: A Minireview.
Genta I; Chiesa E; Colzani B; Modena T; Conti B; Dorati R
Pharmaceutics; 2017 Dec; 10(1):. PubMed ID: 29271876
[TBL] [Abstract][Full Text] [Related]
15. Targeted delivery of quercetin via pH-responsive zinc oxide nanoparticles for breast cancer therapy.
Sadhukhan P; Kundu M; Chatterjee S; Ghosh N; Manna P; Das J; Sil PC
Mater Sci Eng C Mater Biol Appl; 2019 Jul; 100():129-140. PubMed ID: 30948047
[TBL] [Abstract][Full Text] [Related]
16. Dual targeting pH responsive chitosan nanoparticles for enhanced active cellular internalization of gemcitabine in non-small cell lung cancer.
Kumar K; Rawat SG; Manjit ; Mishra M; Priya ; Kumar A; Chawla R
Int J Biol Macromol; 2023 Sep; 249():126057. PubMed ID: 37524283
[TBL] [Abstract][Full Text] [Related]
17. Selenium nanoparticles fabricated in Undaria pinnatifida polysaccharide solutions induce mitochondria-mediated apoptosis in A375 human melanoma cells.
Chen T; Wong YS; Zheng W; Bai Y; Huang L
Colloids Surf B Biointerfaces; 2008 Nov; 67(1):26-31. PubMed ID: 18805679
[TBL] [Abstract][Full Text] [Related]
18. Effect of chitosan oligosaccharide-conjugated selenium on improving immune function and blocking gastric cancer growth.
Jiang Z; Chi J; Li H; Wang Y; Liu W; Han B
Eur J Pharmacol; 2021 Jan; 891():173673. PubMed ID: 33098836
[TBL] [Abstract][Full Text] [Related]
19. Biogenic selenium nanoparticles induce ROS-mediated necroptosis in PC-3 cancer cells through TNF activation.
Sonkusre P; Cameotra SS
J Nanobiotechnology; 2017 Jun; 15(1):43. PubMed ID: 28592284
[TBL] [Abstract][Full Text] [Related]
20. Self-Activating Therapeutic Nanoparticle: A Targeted Tumor Therapy Using Reactive Oxygen Species Self-Generation and Switch-on Drug Release.
Kang RH; Kim Y; Kim JH; Kim NH; Ko HM; Lee SH; Shim I; Kim JS; Jang HJ; Kim D
ACS Appl Mater Interfaces; 2021 Jul; 13(26):30359-30372. PubMed ID: 34142813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
